Jasper Therapeutics JSPR Stock
Jasper Therapeutics Price Chart
Jasper Therapeutics JSPR Financial and Trading Overview
| Jasper Therapeutics stock price | 0.56 USD |
| Previous Close | 0.59 USD |
| Open | 0.6 USD |
| Bid | 0.41 USD x 200 |
| Ask | 0.72 USD x 200 |
| Day's Range | 0.57 - 0.6 USD |
| 52 Week Range | 0.32 - 2.69 USD |
| Volume | 104.71K USD |
| Avg. Volume | 1.37M USD |
| Market Cap | 19.13M USD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.04 USD |
| Forward Dividend & Yield | N/A (0%) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20 USD |
JSPR Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | -0.22460938 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 11.5 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Jasper Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | -75.59% |
| S&P500 52-Week Change | 15.77% |
| 52 Week High | 2.69 USD |
| 52 Week Low | 0.32 USD |
| 50-Day Moving Average | 0.68 USD |
| 200-Day Moving Average | 0.97 USD |
JSPR Share Statistics
| Avg. Volume (3 month) | 1.37M USD |
| Avg. Daily Volume (10-Days) | 414.64K USD |
| Shares Outstanding | 33.27M |
| Float | N/A |
| Short Ratio | 10.53 |
| % Held by Insiders | 2.85% |
| % Held by Institutions | 39.27% |
| Shares Short | 5.81M |
| Short % of Float | 17.78% |
| Short % of Shares Outstanding | 17.45% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -1.04 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 0.05 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Jasper Therapeutics
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 2200 Bridge Pkwy |
| ZIP | 94065 |
| Phone | 650-549-1400 |
| Website | https://jaspertx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, such as chronic urticarias and allergic asthma; and KP-701, a novel, dual-acting anti-CD79BxCD32B monoclonal antibody (mAb) for autoantibody-mediated disorders. The company is based in Redwood City, California.
Q&A For Jasper Therapeutics Stock
What is a current JSPR stock price?
Jasper Therapeutics JSPR stock price today per share is 0.56 USD.
How to purchase Jasper Therapeutics stock?
You can buy JSPR shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jasper Therapeutics?
The stock symbol or ticker of Jasper Therapeutics is JSPR.
Which industry does the Jasper Therapeutics company belong to?
The Jasper Therapeutics industry is Biotechnology.
How many shares does Jasper Therapeutics have in circulation?
The max supply of Jasper Therapeutics shares is 33.27M.
What is Jasper Therapeutics Price to Earnings Ratio (PE Ratio)?
Jasper Therapeutics PE Ratio is now.
What was Jasper Therapeutics earnings per share over the trailing 12 months (TTM)?
Jasper Therapeutics EPS is -1.04 USD over the trailing 12 months.
Which sector does the Jasper Therapeutics company belong to?
The Jasper Therapeutics sector is Healthcare.
Jasper Therapeutics JSPR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
27176.23 USD — |
-1.32
|
6.01B USD — | 27066.76 USD — | 27491.9 USD — | — - | 6.01B USD — |
|
US Tech Health Care
IXHC
US
|
1286.51 USD — |
-0.72
|
— — | 1265.56 USD — | 1286.64 USD — | — - | — — |
- {{ link.label }} {{link}}
